Simplex Trading
TRML

Simplex Trading’s Tourmaline Bio TRML Stock Holding History

Simplex Trading’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,200
Closed -$105K – 10100
2025
Q3 		$105K Buy
2,200
+2,000
+1,000% +$55.5K ﹤0.01% 5685
2025
Q2 		$3K Sell
200
-800
-80% -$13K ﹤0.01% 8039
2025
Q1 		$15K Buy
1,000
+900
+900% +$14.4K ﹤0.01% 6810
2024
Q4 		$2K Sell
100
-300
-75% -$7.55K ﹤0.01% 8091
2024
Q3 		$10K Buy
400
+100
+33% +$1.67K ﹤0.01% 7210
2024
Q2 		$3K Sell
300
-900
-75% -$14.5K ﹤0.01% 8175
2024
Q1 		$27K Buy
+1,200
New +$42.3K ﹤0.01% 6849

Simplex Trading's TRML Position: Q3 2025 in Review

Simplex Trading sold out of Tourmaline Bio (TRML) in Q3 2025, closing a stake of 11 shares — an estimated $305 sold.

Simplex Trading first reported a position in TRML in Q1 2024 and held it in 3 quarters. The position peaked at $46K in Q1 2024. 134 funds tracked by Wall St. Rank hold TRML as of Q3 2025.

  • Simplex Trading reported no remaining Tourmaline Bio position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 11 Tourmaline Bio shares in Q3 2025, an estimated $305.
  • Simplex Trading first reported a position in Tourmaline Bio in Q1 2024 and held it in 3 quarters.
  • Simplex Trading's Tourmaline Bio position peaked at $46K in Q1 2024.
  • 134 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.